Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 242 results found. Search for [ India's drug regulator ]

Results 1 to 21 of 242
PTI
June 12, 2021
NITI Aayog member (Health) V K Paul said each country has its own regulatory system which India respects and hoped that the manufacturer will be able to comply with it by doing whatever requires to be done


BusinessToday.In
June 2, 2021
Like other nations, the Indian government is also expected to grant indemnity to foreign drugmakers like Pfizer and Moderna if they seek drug regulator's nod for the Emergency Use Authorisation (EUA)


PB Jayakumar
June 2, 2021
DCGI said the requirement of conducting post approval bridging clinical trials and requirement of testing of every batch of vaccine by the CDL can be exempted, if the vaccine lot/batch is certified and released by National Control Laboratory of country of origin


Reuters
June 1, 2021
Biological E. will run a clinical trial of Providence's vaccine in India and seek emergency use approval for it, the company said in a statement


BusinessToday.In
June 1, 2021
Lilly is engaging in dialogue with government and regulatory authorities to donate bamlanivimab and etesevimab to speed up access and provide treatment options for patients with COVID-19, says the company


PB Jayakumar
May 27, 2021
Zydus is the only Indian company which claims to have developed a neutralising monoclonal antibodies (mAbs) based cocktail for the treatment of COVID 19


Reuters
May 22, 2021
India has not given any manufacturer of a COVID-19 vaccine indemnity against the costs of compensation for any severe side effects


PTI
May 17, 2021
The advisory has been issued to inform people about minimum standards of oxygen concentrators for COVID-19 case management, especially for use in home settings, the Central Drugs Standard Control Organisation (CDSCO) said


PTI
May 16, 2021
Moderna has been widely used in countries such as Canada, United States and the United Kingdom under emergency use authorisations granted by these countries and the World Health Organisation.


PTI
May 9, 2021
Tata Sons President (Infrastructure, Defence, Aerospace and Global Corporate Affairs) Banmali Agrawala said people need to be vaccinated faster but safely as well


BusinessToday.In
May 4, 2021
Bajaj Healthcare Limited (BHL) has received approval from India's drug regulator, to manufacture and market 'Favijaj' in India for the treatment of COVID-19 from May 4, 2021, onwards


BusinessToday.In
April 22, 2021
If the coronavirus vaccine developed by Biological E gets emergency authorisation, it will be the fourth vaccine against coronavirus in India


PTI
April 20, 2021
The company has sought an early meeting of the subject expert committee on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) to take a decision on its application


Reuters
April 16, 2021
Facing soaring cases and overflowing hospitals after lockdown restrictions were eased, it also abruptly changed the rules to allow it to fast-track vaccine imports, having earlier rebuffed foreign drugmakers like Pfizer


Joe C Mathew
April 15, 2021
India will provide approvals to COVID-19 vaccines approved by health regulators like US FDA within 3 days; detailled guidelines to come soon


BusinessToday.In
April 14, 2021
A total of 82,339 patients were discharged in the past 24 hours. As of April 14, India's total case tally stands at 1.38 crore; total recoveries 1.2 crore; active cases 13.6 lakh; and 1.72 lakh patients have died


BusinessToday.In
April 13, 2021
The vaccines which are listed in World Health Organization's (WHO) emergency use listing will also be granted emergency use approval in India.


BusinessToday.In
April 13, 2021
India is the leading production hub for Sputnik V. RDIF has signed pacts with Gland Pharma, Hetero Biopharma, Panacea Biotec, Stelis Biopharma, Virchow Biotech to produce over 850 million doses per year


BusinessToday.In
April 12, 2021
Of around 20 coronavirus vaccines in several clinical and pre-clinical stages, Russia's Sputnik V may get SEC's nod first


Joe C Mathew
April 11, 2021
India's two approved COVID-19 vaccine makers - Serum Institute of India and Bharat Biotech - are struggling to keep pace with the increasing demand for COVID-19 vaccines within India


PAGES 1 OF 13  12345